Tech Company Financing Transactions
Embody Funding Round
On 5/7/2020, Embody landed $9.3 million in Series A financing from Litigit, 757 Angels and cultivate(MD).
Transaction Overview
Company Name
Announced On
5/7/2020
Transaction Type
Venture Equity
Amount
$9,300,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its team and the commercial launch Tapestry, its next-generation soft-tissue repair technology in the second half of 2020.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4211 Monarch Way 500
Norfolk, VA 23508
USA
Norfolk, VA 23508
USA
Phone
Website
Email Address
Overview
Embody, Inc., is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration. Leveraging our expertise in biomaterial design, biofabrication, nanotechnology, and medical devices, we are engineering implantable devices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Conroy
Chief Scientific Officer
Michael Francis
VP - Bus. Development
Robert Brown
VP - Engineering
Nathan Kemper
VP - Manufacturing
Christy Nelson
VP - Operations
Jeffrey Sirianni
Browse more venture capital transactions:
Prev: 5/7/2020: TimeDoc Health venture capital transaction
Next: 5/7/2020: Emtrain venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs